retatrutide safety trials clinical efficacy Retatrutide, an experimental weight-loss drug, has not been approved by retatrutide clinical trial results safety – Retatrutide for weight loss: Study

Connective Tissue Health It keeps your skin, nails, and joints strong and resilient

In November 2021, Health Canada approved Wegovy, a higher-dose formulation of semaglutide specifically indicated for chronic weight management in adults with obesity (BMI 30 or greater) or overweight (BMI 27 or greater) with at least one weight-related comorbidity

From there, your doctor may increase your dose by 2.5 mg increments every month, depending on your treatment goals and how your body responds

You should immediately place it in the freezer or refrigerator for proper storage and proceed with your research, but be mindful of this deviation

Thats why some providers recommend staying on the medication longer than just until the scale hits a target number